{"generic":"Rotavirus Vaccine, Live, Pentavalent","drugs":["RotaTeq","Rotavirus Vaccine, Live, Pentavalent"],"mono":{"0":{"id":"928518-s-0","title":"Generic Names","mono":"Rotavirus Vaccine, Live, Pentavalent"},"1":{"id":"928518-s-1","title":"Dosing and Indications","sub":{"1":{"id":"928518-s-1-5","title":"Pediatric Dosing","mono":"<ul><li><b>Viral gastroenteritis due to Rotavirus; Prophylaxis:<\/b> As of May 14, 2010, the US Food and Drug Administration (FDA) has recommended that clinicians continue use of the RotaTeq(R) vaccine despite the presence of porcine circovirus type-1 DNA (PCV1) and type-2 DNA (PCV2) in the vaccine, as there is no evidence of a safety risk<\/li><li><b>Viral gastroenteritis due to Rotavirus; Prophylaxis:<\/b> RotaTeq(R), 2 mL (entire pouch) ORALLY at 6 to 12 weeks of age, second and third dose at 4- to 10-week intervals; third dose should not be given after 32 weeks of age (manufacturer dosing)  OR 3-dose series at age 2, 4, and 6 months (guideline dosing)<\/li><\/ul>"},"3":{"id":"928518-s-1-7","title":"Indications","mono":"<b>FDA-Labeled Indications<\/b><br\/>Viral gastroenteritis due to Rotavirus; Prophylaxis<br\/>"}}},"3":{"id":"928518-s-3","title":"Contraindications\/Warnings","sub":[{"id":"928518-s-3-9","title":"Contraindications","mono":"<ul><li>intussusception, history of<\/li><li>severe allergic reaction (eg, anaphylaxis) after a previous dose or to a vaccine component (CDC); hypersensitivity to any component of the vaccine (manufacturer)<\/li><li>Severe Combined Immunodeficiency Disease (SCID)<\/li><\/ul>"},{"id":"928518-s-3-10","title":"Precautions","mono":"<ul><li>acute illness with or without fever, moderate or severe; defer vaccination unless the benefit of protection outweighs the risk of an adverse reaction<\/li><li>bladder exstrophy<\/li><li>gastrointestinal disorders, history of (chronic diarrhea and failure to thrive, congenital abdominal disorders, abdominal surgery, or active acute gastrointestinal illness); no safety and efficacy data<\/li><li>immunocompromised infants (malignancies, HIV\/AIDS, cellular immune deficiencies, hypo- or dysgammaglobulinemia, or receiving immunosuppressive therapy); no safety and efficacy data<\/li><li>infants who received blood transfusion, blood products, including immunoglobulins, within 42 days; no safety or efficacy data<\/li><li>infants with blood dyscrasias, leukemia, lymphomas, or other malignant neoplasms affecting bone marrow or lymphatic system; no safety or efficacy data<\/li><li>recipients who have close contacts to individuals with immunodeficiencies (malignancies, primary immunodeficiency, immunocompromised, or receiving immunosuppressive therapy); transmission of vaccine virus strains from vaccinees to non-vaccinated contacts has been reported<\/li><li>spina bifida<\/li><li>report any adverse events through the Vaccine Adverse Event Reporting System (VAERS) at 1-800-822-7967 or www.vaers.hhs.gov<\/li><\/ul>"},{"id":"928518-s-3-11","title":"Pregnancy Category","mono":"<ul><li>Rotavirus Vaccine, Live: C (FDA)<\/li><li>Rotavirus Vaccine, Live: B2 (AUS)<\/li><\/ul>"},{"id":"928518-s-3-12","title":"Breast Feeding","mono":"Rotavirus Vaccine, Live: Micromedex: Infant risk is minimal.<br\/>"}]},"4":{"id":"928518-s-4","title":"Drug Interactions","sub":[{"id":"928518-s-4-13","title":"Contraindicated","mono":"<ul><li>Aclarubicin (established)<\/li><li>Aldesleukin (established)<\/li><li>Altretamine (established)<\/li><li>Amonafide (established)<\/li><li>Amsacrine (established)<\/li><li>Asparaginase (established)<\/li><li>Azacitidine (established)<\/li><li>Betamethasone (established)<\/li><li>Bleomycin (established)<\/li><li>Broxuridine (established)<\/li><li>Busulfan (established)<\/li><li>Capecitabine (established)<\/li><li>Carboplatin (established)<\/li><li>Carmustine (established)<\/li><li>Chlorambucil (established)<\/li><li>Cisplatin (established)<\/li><li>Cladribine (established)<\/li><li>Corticotropin (established)<\/li><li>Cortisone (established)<\/li><li>Cosyntropin (established)<\/li><li>Cyclophosphamide (established)<\/li><li>Cytarabine (established)<\/li><li>Cytarabine Liposome (established)<\/li><li>Dacarbazine (established)<\/li><li>Dactinomycin (established)<\/li><li>Daunorubicin (established)<\/li><li>Daunorubicin Citrate Liposome (established)<\/li><li>Decitabine (established)<\/li><li>Deflazacort (established)<\/li><li>Dexamethasone (established)<\/li><li>Docetaxel (established)<\/li><li>Doxifluridine (established)<\/li><li>Doxorubicin (established)<\/li><li>Doxorubicin Hydrochloride Liposome (established)<\/li><li>Edatrexate (established)<\/li><li>Eflornithine (established)<\/li><li>Epirubicin (established)<\/li><li>Estramustine (established)<\/li><li>Etoposide (established)<\/li><li>Floxuridine (established)<\/li><li>Fludarabine (established)<\/li><li>Fludrocortisone (established)<\/li><li>Fluocortolone (established)<\/li><li>Fluorouracil (established)<\/li><li>Fotemustine (established)<\/li><li>Gallium Nitrate (established)<\/li><li>Gemcitabine (established)<\/li><li>Hydrocortisone (established)<\/li><li>Hydroxyurea (established)<\/li><li>Idarubicin (established)<\/li><li>Ifosfamide (established)<\/li><li>Interferon Alfa (established)<\/li><li>Interferon Alfacon-1 (established)<\/li><li>Interferon Beta (established)<\/li><li>Interferon Beta-1a (established)<\/li><li>Interferon Beta-1b (established)<\/li><li>Interferon Gamma (established)<\/li><li>Irinotecan (established)<\/li><li>Lomustine (established)<\/li><li>Mechlorethamine (established)<\/li><li>Melphalan (established)<\/li><li>Mercaptopurine (established)<\/li><li>Methotrexate (established)<\/li><li>Methylprednisolone (established)<\/li><li>Mitolactol (established)<\/li><li>Mitomycin (established)<\/li><li>Mitotane (established)<\/li><li>Mitoxantrone (established)<\/li><li>Oxaliplatin (established)<\/li><li>Paclitaxel (established)<\/li><li>Paclitaxel Protein-Bound (established)<\/li><li>Paramethasone (established)<\/li><li>Pegaspargase (established)<\/li><li>Pentostatin (established)<\/li><li>Pipobroman (established)<\/li><li>Pirarubicin (established)<\/li><li>Plicamycin (established)<\/li><li>Prednisolone (established)<\/li><li>Prednisone (established)<\/li><li>Procarbazine (established)<\/li><li>Raltitrexed (established)<\/li><li>Rituximab (established)<\/li><li>Streptozocin (established)<\/li><li>Teceleukin (established)<\/li><li>Tegafur (established)<\/li><li>Teniposide (established)<\/li><li>Thioguanine (established)<\/li><li>Thiotepa (established)<\/li><li>Topotecan (established)<\/li><li>Treosulfan (established)<\/li><li>Triamcinolone (established)<\/li><li>Trimetrexate (established)<\/li><li>Trofosfamide (established)<\/li><li>Uracil Mustard (established)<\/li><li>Vinblastine (established)<\/li><li>Vincristine (established)<\/li><li>Vincristine Sulfate Liposome (established)<\/li><li>Vindesine (established)<\/li><li>Vinorelbine (established)<\/li><\/ul>"},{"id":"928518-s-4-14","title":"Major","mono":"<ul><li>Adalimumab (theoretical)<\/li><li>Alemtuzumab (established)<\/li><li>Azathioprine (established)<\/li><li>Certolizumab Pegol (theoretical)<\/li><li>Cyclosporine (theoretical)<\/li><li>Etanercept (established)<\/li><li>Everolimus (theoretical)<\/li><li>Fingolimod (theoretical)<\/li><li>Golimumab (theoretical)<\/li><li>Immune Globulin (probable)<\/li><li>Infliximab (theoretical)<\/li><li>Mycophenolic Acid (theoretical)<\/li><li>Rilonacept (theoretical)<\/li><li>Secukinumab (theoretical)<\/li><li>Siltuximab (theoretical)<\/li><li>Sirolimus (probable)<\/li><li>Tacrolimus (theoretical)<\/li><li>Temsirolimus (theoretical)<\/li><li>Teriflunomide (theoretical)<\/li><li>Trabectedin (theoretical)<\/li><li>Ustekinumab (theoretical)<\/li><\/ul>"},{"id":"928518-s-4-15","title":"Moderate","mono":"<ul><li>Abatacept (probable)<\/li><li>Cytomegalovirus Immune Globulin, Human (probable)<\/li><li>Hepatitis B Immune Globulin (probable)<\/li><li>Leflunomide (established)<\/li><li>Rabies Immune Globulin (probable)<\/li><li>Respiratory Syncytial Virus Immune Globulin, Human (probable)<\/li><li>Tetanus Immune Globulin (probable)<\/li><li>Vaccinia Immune Globulin, Human (probable)<\/li><li>Varicella-Zoster Immune Globulin (probable)<\/li><\/ul>"}]},"5":{"id":"928518-s-5","title":"Adverse Effects","mono":"<b>Common<\/b><ul><li><b>Gastrointestinal:<\/b>Diarrhea (6.1% to 10.4%), Vomiting (3.6% to 6.7%)<\/li><li><b>Otic:<\/b>Otitis media (14.5%)<\/li><li><b>Psychiatric:<\/b>Irritability (2.9% to 8.1%)<\/li><li><b>Respiratory:<\/b>Bronchospasm (1.1%)<\/li><\/ul><b>Serious<\/b><ul><li><b>Gastrointestinal:<\/b>Gastroenteritis (0.2%)<\/li><li><b>Immunologic:<\/b>Anaphylaxis, Severe combined immunodeficiency disease<\/li><li><b>Neurologic:<\/b>Seizure (less than 0.1%)<\/li><li><b>Other:<\/b>Angioedema<\/li><\/ul>"},"6":{"id":"928518-s-6","title":"Drug Name Info","sub":{"0":{"id":"928518-s-6-17","title":"US Trade Names","mono":"RotaTeq<br\/>"},"2":{"id":"928518-s-6-19","title":"Class","mono":"Vaccine<br\/>"},"3":{"id":"928518-s-6-20","title":"Regulatory Status","mono":"RX<br\/>"}}},"7":{"id":"928518-s-7","title":"Mechanism Of Action","mono":"The rotavirus live pentavalent vaccine (Rotateq(R) contains 5 live reassortant rotaviruses, with rotavirus parent strains of the reassortants isolated from human and bovine hosts. Although the exact mechanism of pentavalent live rotavirus vaccine is unclear, it contains a live, attenuated human rotavirus that replicates in the small intestine and induces immunity against gastroenteritis.<br\/>"},"8":{"id":"928518-s-8","title":"Pharmacokinetics","sub":[{"id":"928518-s-8-23","title":"Absorption","mono":"Effect of food: none <br\/>"}]},"9":{"id":"928518-s-9","title":"Administration","mono":"<b>Oral<\/b><br\/><ul><li>may be administered with food and liquid, including breast milk, either before or after vaccination<\/li><li>if infant regurgitates, spits out, or vomits during or after administration, it is not recommended to readminister the dose; remaining recommended doses should be given at the appropriate intervals<\/li><li>do not mix with any other vaccines or solution<\/li><li>do not reconstitute or dilute<\/li><li>administer as soon as possible after removal from refrigeration<\/li><\/ul>"},"13":{"id":"928518-s-13","title":"Clinical Teaching","mono":"<ul><li>This drug may cause diarrhea or vomiting.<\/li><li>Advise patient to call healthcare professional if a treatment is missed, as drug should be given on a fixed schedule.<\/li><\/ul>"}}}